Cornerstone Planning Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9K Buy
333
+1
+0.3% +$103 ﹤0.01% 515
2026
Q1
$37.2K Sell
332
-4
-1% -$381 0.01% 480
2025
Q4
$28.6K Hold
336
﹤0.01% 494
2025
Q3
$29.8K Buy
336
+283
+534% +$25.3K ﹤0.01% 473
2025
Q2
$4.54K Sell
53
-52
-50% -$4.35K ﹤0.01% 748
2025
Q1
$9.4K Buy
105
+78
+289% +$7.26K ﹤0.01% 591
2024
Q4
$2.67K Hold
27
﹤0.01% 716
2024
Q3
$2.44K Hold
27
﹤0.01% 722
2024
Q2
$2.17K Hold
27
﹤0.01% 745
2024
Q1
$2K Hold
27
﹤0.01% 665
2023
Q4
$1.53K Hold
27
﹤0.01% 669
2023
Q3
$1.47K Sell
27
-104
-79% -$6.16K ﹤0.01% 719
2023
Q2
$8.81K Buy
+131
New +$7.99K ﹤0.01% 713
2022
Q4
$6.11K Buy
+131
New +$6.13K ﹤0.01% 796

Other funds holding LMAT

Cornerstone Planning Group's LMAT Position: Q2 2026 in Review

Cornerstone Planning Group increased its LeMaitre Vascular (LMAT) stake by 0.3% in Q2 2026, buying an estimated $103 and bringing the position to 333 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Cornerstone Planning Group first reported a position in LMAT in Q4 2022 and has held it in 14 quarters since. The position peaked at $37.2K in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Cornerstone Planning Group held 333 shares of LeMaitre Vascular worth $32.9K as of Q2 2026.
  • Cornerstone Planning Group bought 1 LeMaitre Vascular share in Q2 2026, an estimated $103.
  • LeMaitre Vascular made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #515 holding.
  • Cornerstone Planning Group first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 14 quarters since.
  • Cornerstone Planning Group's LeMaitre Vascular position peaked at $37.2K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.